James Investment Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OCR
OMNICARE INC
OCR
|
+$19.6M |
| 2 |
Kroger
KR
|
+$15.9M |
| 3 |
Westlake Corp
WLK
|
+$13.7M |
| 4 |
Goldman Sachs
GS
|
+$12.5M |
| 5 |
IM
Ingram Micro
IM
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$10.9M |
| 2 |
TGI
Triumph Group
TGI
|
+$10.9M |
| 3 |
Timken Company
TKR
|
+$8.84M |
| 4 |
Lennar Class A
LEN
|
+$8.59M |
| 5 |
Valero Energy
VLO
|
+$8.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.3% |
| 2 | Financials | 11.83% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Energy | 7.82% |
| 5 | Technology | 7.51% |
Similar funds
James Investment Research's Q4 2013 Portfolio in Review
As of Q4 2013, James Investment Research held 572 positions worth $3.18B, up 21% from $2.63B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
James Investment Research deployed $224M of net new capital in Q4 2013, opening 52 new positions and adding to 185 existing holdings. Its largest new stake was Tesco Corp: 325,900 shares worth $6.45M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Target, an estimated $10.9M trimmed.
- James Investment Research's largest Q4 2013 buy was Tesco Corp: 325,900 shares worth $6.45M.
- James Investment Research added most to OMNICARE INC in Q4 2013, an estimated $19.6M increase.
- James Investment Research's biggest Q4 2013 reduction was Target, cutting an estimated $10.9M.
- James Investment Research fully exited BROOKFIELD OFFICE PROPERTIES. INC in Q4 2013, selling an estimated $4.61M.
- James Investment Research's ten largest holdings make up 18% of its $3.18B portfolio in Q4 2013.
- James Investment Research opened 52 new positions and closed 41 in Q4 2013.
- James Investment Research's portfolio value rose 21% quarter-over-quarter to $3.18B.
Based on James Investment Research's 13F filing for Q4 2013, filed 23 Jan 2014.